Depot-formulated subcutaneous immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Depot-formulated subcutaneous immunotherapy, covering 2017-10-20 to 2017-10-20. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites [Phase 1]